Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Mount Sinai Beth Israel located at First Avenue And 16Th Street, New York, NY, 10003 & includes data from NPIs 1174689665, 1649415571, 1063657963
Dexur analyzed Q4 2016 (October to December 2016) Medicare claims data to benchmark 30 Day readmissions outcomes for Mount Sinai Beth Israel compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,318 | 1,242 | ||||||||||
| Surgical | 403 | 394 | ||||||||||
| Non Surgical | 915 | 848 | ||||||||||
| Cardiovascular | 288 | 273 | ||||||||||
| General Medicine | 202 | 186 | ||||||||||
| Orthopedics | 134 | 131 | ||||||||||
| Psychiatry & Mental Disorders | 133 | 125 | ||||||||||
| General Surgery | 115 | 110 | ||||||||||
| Gastroenterology & Endocrinology | 113 | 106 | ||||||||||
| Pulmonology | 85 | 79 | ||||||||||
| Urology | 76 | 72 | ||||||||||
| Neurology | 65 | 62 | ||||||||||
| Oncology & Hematology | 45 | 37 | ||||||||||
| Colorectal | 19 | 19 | ||||||||||
| Spine | 15 | 15 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 12 | 12 |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Circulatory System Diagnoses |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| Complications Of Treatment |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Biliary Tract |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| Degenerative Nervous System Disorders |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |